Browse Articles

Reducing tremors in LRRK2-G2019S genetically-mutated Parkinson’s flies with a lovastatin–levodopa combination

Foell et al. | Nov 11, 2026

Reducing tremors in LRRK2-G2019S genetically-mutated Parkinson’s flies with a lovastatin–levodopa combination
Image credit: Authors

Here the authors investigated alternative treatments for Parkinson's disease tremors, this study tested whether replacing the traditional carbidopa component with lovastatin in a levodopa combination would improve symptom reduction in a Drosophila melanogaster model. The findings revealed that the lovastatin–levodopa combination was more optimal at reducing tremors than the standard treatment, pointing to a potentially superior therapeutic approach for future investigation.

Read More...

Measuring effects of caffeine and melatonin on learning trends of Zebrafish juveniles

Wei et al. | Jun 28, 2026

Measuring effects of caffeine and melatonin on learning trends of Zebrafish juveniles

This study investigates how caffeine and melatonin affect learning in adolescent zebrafish, serving as a model for human teens. Using an automated system to track behavior, we found that melatonin slowed learning while caffeine caused erratic, inconsistent responses, suggesting both substances can negatively impact adolescent learning patterns. These findings highlight the need for further research into their physiological effects and potential implications for human adolescents.

Read More...

Development of selective RAC1/KLRN inhibitors

Kubrat Neczaj-Hruzewicz et al. | Nov 04, 2024

Development of selective RAC1/KLRN inhibitors

Kalirin is a guanine nucleotide exchange factor (GEF) for the GTPase RAC1, linked to schizophrenia and Alzheimer’s Disease. It plays a crucial role in synaptic plasticity by regulating dendritic spine formation and actin cytoskeleton remodeling, which are essential for creating new synapses. Authors developed two novel compounds targeting kalirin, confirming that predictive modeling can indicate biological activity.

Read More...

Near-infrared activation of environmentally-friendly gold and silver nanoparticles for unclogging arteries

Gill et al. | Sep 06, 2024

Near-infrared activation of environmentally-friendly gold and silver nanoparticles for unclogging arteries

Coronary artery disease, the leading cause of death worldwide, results from cholesterol build-up in coronary arteries, limiting blood and oxygen flow to the heart. This study investigated the use of gold and silver nanoparticles coated with aspirin and activated by near-infrared light to improve blood flow in a clogged artery model. The nanoparticles increased simulated blood flow rates, demonstrating potential as a less invasive and more targeted treatment for cardiovascular disease.

Read More...